--2025/Q1-- / 3.829B--
--2024/Q4-- / 4.091B--
Nov 6, 20242024/Q34.332B / 4.125B--
Jul 31, 20242024/Q24.164B / 4.045B--
May 8, 20242024/Q13.819B / 3.740B--
US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 16.430
- -0.320-1.91%
Close Nov 15 16:00 ET
- 16.440
- +0.010+0.06%
Post 20:02 ET
18.62BMarket Cap-19329P/E (TTM)
16.630High16.160Low8.73MVolume16.220Open16.750Pre Close143.84MTurnover0.78%Turnover RatioLossP/E (Static)1.13BShares19.31052wk High3.07P/B18.51BFloat Cap9.04052wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM2.81%Amplitude3.107Historical Low16.468Avg Price1Lot Size
Teva Pharmaceutical Industries Key Stats
Teva Pharmaceutical Industries Q3 2024 Earnings Date
Currency：USDNov 6, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 4.13B | 4.33B | +206.96M |
| Beat Est. | +7.14% | +12.52% | +5.02% |
| EPS | -<0.01 | -0.39 | -0.39 |
| Miss Est. | -103.57% | -750.00% | -15500.00% |
Analyst Rating
Nov 11, 2024
Teva Pharmaceutical Industries Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Teva Pharmaceutical Industries Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
